The end of cataract surgery? Experts say vision-robbing condition may soon be treated with DRUGS
A team of scientists, led by Professor Barbara Pierscionek at Anglia Ruskin University in London, tested a compound proposed as an anti-cataract drug on mice. (Source: the Mail online | Health)
Source: the Mail online | Health - May 16, 2022 Category: Consumer Health News Source Type: news

NHS waiting list spikes to ANOTHER record high: Now 6.4MILLION patients are stuck in queues
NHS data shows one in nine people were in the queue for elective operations such as hip and knee replacements and cataracts surgery by March. (Source: the Mail online | Health)
Source: the Mail online | Health - May 12, 2022 Category: Consumer Health News Source Type: news

Paediatric traumatic cataracts in Southwest China: epidemiological profile - Wang P, Fu Q, Yin H, Wang L, Liu L.
This study aimed to characterize the epidemiological... (Source: SafetyLit)
Source: SafetyLit - May 9, 2022 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Eyesight: Cataracts, dry eye or glaucoma are among menopause warning signs in eyes
EYESIGHT is known to be affected when a woman enters the menopause. How can the condition affect a women's eyesight? (Source: Daily Express - Health)
Source: Daily Express - Health - April 29, 2022 Category: Consumer Health News Source Type: news

Featured review: Surgery on both eyes on the same day or on different days: which works better to treat cataract in both eyes?
Wednesday, April 27, 2022 (Source: Cochrane News and Events)
Source: Cochrane News and Events - April 27, 2022 Category: Information Technology Authors: Lydia Parsonson Source Type: news

ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise. JENA, Germany and DUBLIN, Ireland , April 20, 2022 -- (Healthcare Sales & Marketing Network) -- Today, ZEISS... Devices, Ophthalmology, FDA Carl Zeiss Meditec, QUATERA 700 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2022 Category: Pharmaceuticals Source Type: news

NHS waiting list hits ANOTHER high amid Covid-fuelled crisis: 6.18MILLION waiting for routine ops
NHS England data shows one in nine people in the country are waiting, often in pain, for elective operations such as hip and knee replacements and cataracts surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - April 14, 2022 Category: Consumer Health News Source Type: news

Elective recovery plan delivers
Same-day hip replacements, one stop shops and mobile cataract units are just some of the ways NHS staff are helping hundreds of thousands of patients receive faster care. (Source: NHS Networks)
Source: NHS Networks - April 14, 2022 Category: UK Health Source Type: news

Eat fatty fish, walk more and take breaks to reverse eye damage caused by years of smoking
ACCUMULATIVE research shows that smoking significantly increases the risk of age-related macular degeneration, cataracts, glaucoma and dry eye syndrome. Aside from becoming a non-smoker, there are other ways to improve your sight. (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2022 Category: Consumer Health News Source Type: news

Patients Should Know Who's Operating, Surgeons Say
(MedPage Today) -- When Chryssa McAlister, MD, was learning to remove cataracts, she trained under some cranky doctors who didn't hesitate to bark critiques. But a few of her supervisors maintained a purposeful silence, soundlessly mouthing their... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - April 5, 2022 Category: Surgery Source Type: news

Patient Blinded in One Eye From Surgery Wins $1.2 Million Patient Blinded in One Eye From Surgery Wins $1.2 Million
A New York appeals court has upheld a $1.2 million verdict against an eye surgeon after his patient went blind after cataract removal and lens replacement surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2022 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Eye health: The warning signs of a growing cataract – 'can lead to vision loss'
THREE Britons in 10, over the age of 65, are likely to develop a visually impairing cataract. Caught early, the condition can be managed at home, but in the later stages, surgery might be needed. (Source: Daily Express - Health)
Source: Daily Express - Health - March 24, 2022 Category: Consumer Health News Source Type: news

Tanzania: 25 Children to Undergo Eye Surgeries
[Daily News] ABOUT 25 children from the Lake Zone are set to undergo surgeries related to eye disorders or diseases such as cataract, glaucoma and blurred vision during the commemoration of Glaucoma Awareness Week launched on Wednesday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 11, 2022 Category: African Health Source Type: news

New two-year data for Roche ’s Vabysmo and Susvimo reinforce potential to maintain vision with fewer treatments for people with two leading causes of vision loss
This study will evaluate the efficacy, safety, and pharmacokinetics of the port delivery system with ranibizumab in participants with diabetic macular edema compared with intravitreal ranibizumab (Pagoda) [Internet; cited January 2022]. Available from:https://clinicaltrials.gov/ct2/show/NCT04108156.[14] ClinicalTrials.gov. A multicenter, randomized study in participants with diabetic retinopathy without center-involved diabetic macular edema to evaluate the efficacy, safety, and pharmacokinetics of ranibizumab delivered via the port delivery system relative to the comparator arm (PAVILION) [Internet; cited January 2022]. A...
Source: Roche Investor Update - February 11, 2022 Category: Pharmaceuticals Source Type: news

New two-year data for Roche ’s Vabysmo and Susvimo reinforce potential to maintain vision with fewer treatments for people with two leading causes of vision loss
This study will evaluate the efficacy, safety, and pharmacokinetics of the port delivery system with ranibizumab in participants with diabetic macular edema compared with intravitreal ranibizumab (Pagoda) [Internet; cited January 2022]. Available from:https://clinicaltrials.gov/ct2/show/NCT04108156.[14] ClinicalTrials.gov. A multicenter, randomized study in participants with diabetic retinopathy without center-involved diabetic macular edema to evaluate the efficacy, safety, and pharmacokinetics of ranibizumab delivered via the port delivery system relative to the comparator arm (PAVILION) [Internet; cited January 2022]. A...
Source: Roche Media News - February 11, 2022 Category: Pharmaceuticals Source Type: news